Effects of adenovirus-mediated SV5 fusogenic glycoprotein expression on tumor cells

Area of Science:

• Virology
• Molecular Biology
• Oncology

Background:

• The paramyxovirus SV5 fusogenic (F) membrane glycoprotein mediates viral entry and cell-to-cell fusion, leading to cell death.
• F glycoprotein is synthesized as an inactive precursor (F(0)) and activated by furin cleavage into F(1) + F(2).
• The active F protein uniquely induces syncytium formation independently of the HN glycoprotein.

Purpose of the Study:

• To investigate the potential of SV5 F glycoprotein as a therapeutic agent against tumor cells.
• To evaluate the cytotoxicity and bystander effect of F glycoprotein expression in tumor cells.
• To compare the efficacy of F glycoprotein-mediated cell killing with thymidine kinase/ganciclovir suicide gene therapy.

Main Methods:

• Construction of a non-replicative adenovirus for SV5 F protein expression in tumor cells.
• Analysis of fusion capacity using fluorescent and confocal microscopy.
• Assessment of cell viability and bystander effect, with structural analysis via electron microscopy.

Main Results:

• SV5 F glycoprotein expression induced significant syncytium formation and cytotoxicity in tumor cells, peaking at 72 hours.
• Cellular membrane disruption occurred while nuclear structure remained intact.
• A potent bystander killing effect was observed, effective even at a 1:100 ratio of F-transduced to non-transduced cells.

Conclusions:

• SV5 fusogenic glycoprotein demonstrates potential for eliminating tumor cells.
• Further research is warranted to enhance F glycoprotein selectivity and combine it with other cytotoxic strategies for improved cancer treatment efficacy.